Varnotech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $84.3M

  • Investors
  • 12

Varnotech General Information

Description

Provider and developer of vaccines and adjuvants designed to combat diseases and viruses. The company is committed in developing strong vaccines, antibodies, and adjuvants, enabling patients with human vaccines and innovative adjuvants.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building 12, No. 1, Kegu 4th Street
  • Beijing Economic and Technological Development Zone
  • Beijing
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1st Floor, Building 12, No. 1, Kegu 4th Street
  • Beijing Economic and Technological Development Zone
  • Beijing
  • China
+86 010

Varnotech Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Varnotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 08-Jan-2024 $84.3M Completed Generating Revenue
4. Early Stage VC 18-Jul-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 08-Mar-2021 Completed Generating Revenue
2. Early Stage VC 26-Feb-2020 Completed Generating Revenue
1. Seed Round 06-Aug-2019 Completed Startup
To view Varnotech’s complete valuation and funding history, request access »

Varnotech Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
3E Bioventures (China) Venture Capital Minority
Beijing Shunxi Private Equity Fund Management Growth/Expansion Minority
Beijing State-owned Capital Operation and Management Government Minority
Huayin Financial Investment Asset Manager Minority
Kinsight Capital PE/Buyout Minority
You’re viewing 5 of 12 investors. Get the full list »

Varnotech FAQs

  • When was Varnotech founded?

    Varnotech was founded in 2019.

  • Where is Varnotech headquartered?

    Varnotech is headquartered in Beijing, China.

  • What industry is Varnotech in?

    Varnotech’s primary industry is Drug Discovery.

  • Is Varnotech a private or public company?

    Varnotech is a Private company.

  • What is Varnotech’s current revenue?

    The current revenue for Varnotech is .

  • How much funding has Varnotech raised over time?

    Varnotech has raised $104M.

  • Who are Varnotech’s investors?

    3E Bioventures (China), Beijing Shunxi Private Equity Fund Management, Beijing State-owned Capital Operation and Management, Huayin Financial Investment, and Kinsight Capital are 5 of 12 investors who have invested in Varnotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process